EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma

[1]  K. Ichimura,et al.  Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report , 2021, Brain Tumor Pathology.

[2]  M. Rosenblum,et al.  Molecular clarification of brainstem astroblastoma with EWSR1-BEND2 fusion in a 38-year-old man. , 2021, Free neuropathology.

[3]  Pieter Wesseling,et al.  cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading , 2020, Brain pathology.

[4]  T. Kohno,et al.  Spinal cord astroblastoma with an EWSR1‐BEND2 fusion classified as a high‐grade neuroepithelial tumour with MN1 alteration , 2019, Neuropathology and applied neurobiology.

[5]  K. Hoang-Xuan,et al.  Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. , 2019, The oncologist.

[6]  R. McLendon,et al.  Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis , 2019, Acta Neuropathologica Communications.

[7]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[8]  T. Tihan,et al.  Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities , 2018, Brain pathology.

[9]  Mariella G. Filbin,et al.  Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors , 2017, Neuro-oncology.

[10]  Arie Perry,et al.  Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy , 2016, Neuro-oncology.

[11]  Roland Eils,et al.  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs , 2016, Cell.

[12]  D. Brat,et al.  Astroblastoma: Clinicopathologic Features and Chromosomal Abnormalities Defined by Comparative Genomic Hybridization , 2000, Brain pathology.

[13]  J. Bonnin,et al.  Astroblastomas: a pathological study of 23 tumors, with a postoperative follow-up in 13 patients. , 1989, Neurosurgery.

[14]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.